Cite
HARVARD Citation
Gratch, D. et al. (2022). Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—Commentary. Multiple sclerosis. pp. 695-696. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gratch, D. et al. (2022). Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing—Commentary. Multiple sclerosis. pp. 695-696. [Online].